| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/16/2008 | CN100361680C Medicine for treating backbone disease |
| 01/16/2008 | CN100361676C Pain stopping ointment for piles |
| 01/16/2008 | CN100361675C Chinese medicine composite preparation for treating blood syndrome of woman |
| 01/16/2008 | CN100361672C Red sage root ligustrazine freeze dried injecta and preparation method thereof |
| 01/16/2008 | CN100361666C Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process |
| 01/16/2008 | CN100361664C Pharmaceutical formulations |
| 01/16/2008 | CN100361663C Gel containing phytosterol and its preparing method |
| 01/16/2008 | CN100361662C Preparation method of traditional Chinese medicine compositions formulation |
| 01/16/2008 | CN100361661C Stable eye lotion containing latanoprost as active ingredient |
| 01/16/2008 | CN100361660C Levofloxacin slow release micropill, its preparation method and uses |
| 01/16/2008 | CN100361659C Composite vitamin B powdery injection for venous infusion and preparation thereof |
| 01/16/2008 | CN100361657C Fluorouracial nano particle formulation and its preparing method |
| 01/16/2008 | CN100361656C Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 01/16/2008 | CN100361655C (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
| 01/16/2008 | CN100361654C Body-building weight-reducing capsule and its preparation process |
| 01/16/2008 | CN100361653C Tiopronin soft capsule |
| 01/16/2008 | CN100361652C Gel type dexketoprofen plaster and method for preparing the same |
| 01/16/2008 | CN100361651C Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| 01/16/2008 | CN100361650C Zhangyanming capsule and preparing process |
| 01/16/2008 | CN100361649C Prepn process of alive adult roach extract |
| 01/15/2008 | US7319117 Mixture containing surfactant and polymer |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319035 Biological scaffolding material |
| 01/15/2008 | US7318939 Herbal formulation for treatment of depression and other related disorders and method of preparing the same |
| 01/15/2008 | US7318936 Minimization of drug oxidation in drug irradiated excipients formulations |
| 01/15/2008 | US7318935 Immediate release, divisible, layered pharmaceutical tablet that has two or more segments, a height that exceeds the width of the tablet, and at least two different active ingredients; calcium channel blocker (amlodipine), an angiotensin converting enzyme inhibitor (benazepril), diuretic (chlorthalidone) |
| 01/15/2008 | US7318934 Method for treating wounds to promote healing |
| 01/15/2008 | US7318931 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; and a metal, e.g., zinc; stabilized against denaturing when in contact with an organic solvent. |
| 01/15/2008 | US7318840 Intervertebral disc treatment devices and methods |
| 01/15/2008 | CA2432225C Sustained release drug delivery devices with prefabricated permeable plugs |
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2339166C Dextran-maleic acid monoesters and hydrogels based thereon |
| 01/15/2008 | CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/15/2008 | CA2312839C Compositions for nasal administration |
| 01/15/2008 | CA2307776C Capsular preparation containing unsaturated fatty acid or derivative thereof and process for producing the same |
| 01/15/2008 | CA2279522C Biocompatible compounds for pharmaceutical drug delivery systems |
| 01/15/2008 | CA2251966C Transdermally administered dextromethorphan as antitussive agent |
| 01/15/2008 | CA2251087C Injection formulations of avermectins and milbemycins based on castor oil |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/15/2008 | CA2244389C Cilansetron pharmaceutical preparation stabilized against racemization |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/15/2008 | CA2152563C Non-reducing saccharide and its production and use |
| 01/15/2008 | CA2132740C Pharmaceutical composition containing cyclosporin derivative |
| 01/10/2008 | WO2008006021A2 Shifter with actuator incorporating shape memory alloy |
| 01/10/2008 | WO2008005742A2 Ibuprofen-containing liquid filled hard capsules |
| 01/10/2008 | WO2008005691A1 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| 01/10/2008 | WO2008005676A2 Injectable collagen material |
| 01/10/2008 | WO2008005580A2 Formulation for treatment of acne |
| 01/10/2008 | WO2008005543A2 Compositions with controlled pharmacokinetics |
| 01/10/2008 | WO2008005534A2 Orally dissolving formulations of memantine |
| 01/10/2008 | WO2008005458A2 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 01/10/2008 | WO2008005353A2 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 01/10/2008 | WO2008005318A2 Chewy products and methods for making the same |
| 01/10/2008 | WO2008005287A1 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/10/2008 | WO2008005276A2 Growth factor delivery system containing antimicrobial agents |
| 01/10/2008 | WO2008005240A2 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
| 01/10/2008 | WO2008005217A2 Iron(ii)-containing treatments for hyperphosphatemia |
| 01/10/2008 | WO2008005053A1 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/10/2008 | WO2008005039A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/10/2008 | WO2008005036A1 Pharmaceutical compositions of memantine |
| 01/10/2008 | WO2008005020A1 Extended release perforated tablet |
| 01/10/2008 | WO2008004908A1 Nootropic medicinal agent |
| 01/10/2008 | WO2008004717A1 A stable liquid formulation of human growth hormone |
| 01/10/2008 | WO2008004542A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 01/10/2008 | WO2008004206A2 Carotenoid compositions useful for whitening skin |
| 01/10/2008 | WO2008004033A1 A stable olanzapine formulation with antioxidants |
| 01/10/2008 | WO2008004001A2 The use of pvp to control the release profile of an active ingredient from a hydrophilic polymer matrix tablet |
| 01/10/2008 | WO2008003983A1 Resorbable insert |
| 01/10/2008 | WO2008003932A1 Hydrophilic polyurethane compositions |
| 01/10/2008 | WO2008003769A2 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 01/10/2008 | WO2008003432A1 Pharmaceutical composition containing a tetrahydrofolic acid |
| 01/10/2008 | WO2008003245A1 The use of rosmarinic acid in the manufacture of medicaments for treating or preventing hepatic and renal diseases |
| 01/10/2008 | WO2007134292A3 Treprostinil administration using a metered dose inhaler |
| 01/10/2008 | WO2007133473A3 Methods for treating or preventing disorders using ecdysteroid compositions |
| 01/10/2008 | WO2007133382A3 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers |
| 01/10/2008 | WO2007132134A3 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof |
| 01/10/2008 | WO2007132022A3 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 01/10/2008 | WO2007122478A3 Multiple unit compositions |
| 01/10/2008 | WO2007117629A3 Impact of calcium phosphate complex on dental caries |
| 01/10/2008 | WO2007117627A3 Calcium phosphate complex and salts in oral delivery systems |
| 01/10/2008 | WO2007116954A3 Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer |
| 01/10/2008 | WO2007104575A3 Stable lozenge compositions providing rapid release of nicotine |
| 01/10/2008 | WO2007104574A3 Chewing gum compositions providing rapid release of nicotine |
| 01/10/2008 | WO2007104173B1 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 01/10/2008 | WO2007095149A3 Press-fit rapid release medicament and method and apparatus of manufacturing |
| 01/10/2008 | WO2007093853A3 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols |
| 01/10/2008 | WO2007071581A3 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 01/10/2008 | WO2007059916A3 Pharmaceutical composition |
| 01/10/2008 | WO2007003330A3 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 01/10/2008 | WO2006127360A3 Lipid construct for delivery of interferon to a mammal |
| 01/10/2008 | WO2006127067A3 A delivery system for coated active components as part of an edible composition |
| 01/10/2008 | WO2004108056A3 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease |
| 01/10/2008 | US20080009898 Treatment for high pressure bleeding |
| 01/10/2008 | US20080009836 Drug delivery apparatus |
| 01/10/2008 | US20080009835 Fluid dispensing apparatus with flow rate control |
| 01/10/2008 | US20080009476 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009042 separating the yeast from the culture medium to yield an albumin solution; subjecting the albumin solution to positive mode cation exchange, affinity, and positive mode anion exchange chromatography; and concentrating and formulating the albumin with sodium octanoate and sodium chloride |